TBD: Patient Safety & Pharmacovigilance program for enhancement of patient safety system in medical institutions
Alessandra Zago Jorgetto
Regional Patient Safety Head - Emerging Market
Boehringer Ingelheim Germany
Considering that 1 in 10 hospitalized patients is affected by an adverse event, with a median of 43% being preventable1, our goal is to reduce unnecessary risk related to medicines in medical institutions around the world, contributing to WHO Global Patient Safety Challenge: Medication Without Harm.
Through a partnership between different stakeholders, an innovative Patient Safety & Pharmacovigilance program focusing on healthcare professionals working in medical institutions has been developed for implementation worldwide based on a successful previous experience in Brazil.
A pilot of a Patient Safety and Pharmacovigilance (PV) program was implemented in Brazil via a partnership between pharma industry, academia, clinical practice and health authority. In 2020 and 2022, a 30-hour online “Patient Safety and Pharmacovigilance” program was offered by Pharmacy College (Universidade de São Paulo) and FIPFARMA (Fundação Instituto de Pesquisas Farmacêuticas) in two different cohorts. There were recorded classes and synchronous meetings about the Overview of Healthcare and Pharmacovigilance, Drug Safety and Management of Drug Utilization and Patient Safety Culture; followed by workshops to co-create solutions for real challenges faced by healthcare professionals. Approximately 100 healthcare professionals (HCPs) were impacted by this initiative, and they expressed the importance of the program to enhance the quality of existing processes in their institutions, improve adverse event notification flow, promote educational activities to other HCPs, including the development of a PV system from scratch in a Covid-19 hospital. The video conference format was an effective tool to reach and activate HCPs, providing knowledge, sharing experiences and changing mindset.
Considering WHO Global Patient Safety Challenge and the successful results achieved with the program pilot in Brazil, a worldwide program has been developed with main objective to provide knowledge and tools to medical institutions around the world in order to enhance their PV and patient safety systems. The establishment of robust processes in PV contributes to higher quality standards for the institution, and, therefore, better outcomes to patients and also to a healthier work environment for HCPs. A partnership across different stakeholders in the society is key to make a difference and improving people’s live, preventing and avoiding any unnecessary risk related to medicines.
1. Ciapponi A, Fernandez Nievas SE, Seijo M, Rodríguez MB, Vietto V, García-Perdomo HA, et al. Reducing medication errors for adults in hospital settings. Cochrane Database Syst Rev. 25 de novembro de 2021;11:CD009985.
The author(s) meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE).
The authors did not receive payment related to the development of this abstract.